On the use of lonafarnib in myelodysplastic syndrome and chronic myelomonocytic leukemia
- Author
- FELDMAN, E. J1 ; CORTES, J2 ; MALOISEL, F10 ; COLOMBAT, P11 ; MARTINELLI, G12 ; NIELSEN, J. L13 ; PETERSDORF, S14 ; GUILHOT, F15 ; BARKER, J16 ; KIRSCHMEIER, P17 ; FRANK, E17 ; STATKEVICH, P17 ; DEANGELO, D. J3 ; ZHU, Y17 ; LOECHNER, S17 ; LIST, A18 ; HOLYOAKE, T4 ; SIMONSSON, B5 ; O'BRIEN, S. G6 ; REIFFERS, J7 ; TURNER, A. R8 ; ROBOZ, G. J1 ; LIPTON, J. H9
[1] Division of Hematology and Medical Oncology, Weill-Cornel Medical College, New York, NY, United States
[2] Department of Leukemia, MD Anderson Cancer Center, Houston, TX, United States
[3] Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA, United States
[4] Division of Cancer and Molecular Pathology, Glasgow Royal Infirmary, Glasgow, United Kingdom
[5] Department of Hematology, University Hospital, Uppsala, Sweden
[6] Department of Hematology, Newcastle University, Newcastle upon Tyne, United Kingdom
[7] Institut Bergonie and Universite Victor Segalen, Bordeaux, France
[8] Division of Medical Oncology, Cross Cancer Institute, Edmonton, Canada
[9] Division of Medical Oncology and Hematology and Oncology, Princess Margaret Hospital, Ontario, Canada
[10] Department of Hematologie-Oncologie, Hopitaux Universitaires de Strasbourg, Strasbourg, France
[11] Department of Hematology, CHU Tours, France
[12] Department of Hematology/Oncology, Universita' di Bologna, Bologna, Italy
[13] Department of Hematology, University Hospital, Arhus, Denmark
[14] Division of Medical Oncology, Seattle Cancer Care Alliance, Seattle, WA, United States
[15] Department of Oncology-Haematology and Cell therapeutics, CIC INSERM 802 C.H.U. de Poitiers, Poitiers, France
[16] Department of Hematology, University of Minnesota, Minneapolis, MN, United States
[17] Schering-Plough Research Institute, Kenilworth, NJ, United States
[18] Malignant Hematology Division, H. Lee Moffit Cancer Center and Research Institute, Tampa, FL, United States - Source
Leukemia. 2008, Vol 22, Num 9, pp 1707-1711, 5 p ; ref : 23 ref
- CODEN
- LEUKED
- ISSN
- 0887-6924
- Scientific domain
- Medical oncology; Hematology
- Publisher
- Nature Publishing, London
- Publication country
- United Kingdom
- Document type
- Article
- Language
- English
- Author keyword
- CMML Ionafarnib MDS
- Keyword (fr)
- Anticancéreux Cancérologie Chimiothérapie Efficacité traitement Farnesyltranstransferase Homme Hématologie Inhibiteur enzyme Lonafarnib Stade avancé Syndrome myélodysplasique Leucemie myélomonocytaire chronique Pharmacodynamie Cancer Enzyme Hémopathie maligne Syndrome myéloprolifératif Traitement Transferases
- Keyword (en)
- Antineoplastic agent Cancerology Chemotherapy Treatment efficiency Farnesyltranstransferase Human Hematology Enzyme inhibitor Lonafarnib Advanced stage Myelodysplastic syndrome Chronic myelomonocytic leukemia Pharmacodynamics Cancer Enzyme Malignant hemopathy Myeloproliferative syndrome Treatment Transferases
- Keyword (es)
- Anticanceroso Cancerología Quimioterapia Eficacia tratamiento Farnesyltranstransferase Hombre Hematología Inhibidor enzima Lonafarnib Estadio avanzado Mielodisplastico síndrome Leucemia mielomonocitaria cronica Farmacodinámica Cáncer Enzima Hemopatía maligna Mieloproliferativo síndrome Tratamiento Transferases
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02R Antineoplastic agents / 002B02R02 Chemotherapy
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B19 Hematologic and hematopoietic diseases / 002B19B Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis
- Discipline
- Blood diseases Pharmacological treatments
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 20666661
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1038/leu.2008.156 
https://dx.doi.org/10.1038/leu.2008.156
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:20:\"10.1038\/leu.2008.156\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:88:\"On the use of lonafarnib in myelodysplastic syndrome and chronic myelomonocytic leukemia\";s:9:\"\u0000*\u0000jtitle\";s:8:\"Leukemia\";s:9:\"\u0000*\u0000stitle\";s:8:\"Leukemia\";s:7:\"\u0000*\u0000date\";s:4:\"2008\";s:9:\"\u0000*\u0000volume\";s:2:\"22\";s:8:\"\u0000*\u0000issue\";s:1:\"9\";s:8:\"\u0000*\u0000spage\";s:4:\"1707\";s:8:\"\u0000*\u0000epage\";s:4:\"1711\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0887-6924\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"FELDMAN\";s:10:\"\u0000*\u0000aufirst\";s:4:\"E. J\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:22:{i:0;s:9:\"CORTES, J\";i:1;s:11:\"MALOISEL, F\";i:2;s:11:\"COLOMBAT, P\";i:3;s:13:\"MARTINELLI, G\";i:4;s:13:\"NIELSEN, J. L\";i:5;s:13:\"PETERSDORF, S\";i:6;s:10:\"GUILHOT, F\";i:7;s:9:\"BARKER, J\";i:8;s:14:\"KIRSCHMEIER, P\";i:9;s:8:\"FRANK, E\";i:10;s:13:\"STATKEVICH, P\";i:11;s:14:\"DEANGELO, D. J\";i:12;s:6:\"ZHU, Y\";i:13;s:11:\"LOECHNER, S\";i:14;s:7:\"LIST, A\";i:15;s:11:\"HOLYOAKE, T\";i:16;s:12:\"SIMONSSON, B\";i:17;s:13:\"O'BRIEN, S. G\";i:18;s:11:\"REIFFERS, J\";i:19;s:12:\"TURNER, A. R\";i:20;s:11:\"ROBOZ, G. J\";i:21;s:12:\"LIPTON, J. H\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"LEUKED\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:88:\"On the use of lonafarnib in myelodysplastic syndrome and chronic myelomonocytic leukemia\";s:8:\"\u0000*\u0000place\";s:6:\"London\";s:6:\"\u0000*\u0000pub\";s:17:\"Nature Publishing\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"5\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:20:\"10.1038\/leu.2008.156\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:88:\"On the use of lonafarnib in myelodysplastic syndrome and chronic myelomonocytic leukemia\";s:9:\"\u0000*\u0000jtitle\";s:8:\"Leukemia\";s:9:\"\u0000*\u0000stitle\";s:8:\"Leukemia\";s:7:\"\u0000*\u0000date\";s:4:\"2008\";s:9:\"\u0000*\u0000volume\";s:2:\"22\";s:8:\"\u0000*\u0000issue\";s:1:\"9\";s:8:\"\u0000*\u0000spage\";s:4:\"1707\";s:8:\"\u0000*\u0000epage\";s:4:\"1711\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0887-6924\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"FELDMAN\";s:10:\"\u0000*\u0000aufirst\";s:4:\"E. J\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:22:{i:0;s:9:\"CORTES, J\";i:1;s:11:\"MALOISEL, F\";i:2;s:11:\"COLOMBAT, P\";i:3;s:13:\"MARTINELLI, G\";i:4;s:13:\"NIELSEN, J. L\";i:5;s:13:\"PETERSDORF, S\";i:6;s:10:\"GUILHOT, F\";i:7;s:9:\"BARKER, J\";i:8;s:14:\"KIRSCHMEIER, P\";i:9;s:8:\"FRANK, E\";i:10;s:13:\"STATKEVICH, P\";i:11;s:14:\"DEANGELO, D. J\";i:12;s:6:\"ZHU, Y\";i:13;s:11:\"LOECHNER, S\";i:14;s:7:\"LIST, A\";i:15;s:11:\"HOLYOAKE, T\";i:16;s:12:\"SIMONSSON, B\";i:17;s:13:\"O'BRIEN, S. G\";i:18;s:11:\"REIFFERS, J\";i:19;s:12:\"TURNER, A. R\";i:20;s:11:\"ROBOZ, G. J\";i:21;s:12:\"LIPTON, J. H\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"LEUKED\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:88:\"On the use of lonafarnib in myelodysplastic syndrome and chronic myelomonocytic leukemia\";s:8:\"\u0000*\u0000place\";s:6:\"London\";s:6:\"\u0000*\u0000pub\";s:17:\"Nature Publishing\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"5\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:20:\"10.1038\/leu.2008.156\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:20:\"10.1038\/leu.2008.156\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:88:\"On the use of lonafarnib in myelodysplastic syndrome and chronic myelomonocytic leukemia\";s:9:\"\u0000*\u0000jtitle\";s:8:\"Leukemia\";s:9:\"\u0000*\u0000stitle\";s:8:\"Leukemia\";s:7:\"\u0000*\u0000date\";s:4:\"2008\";s:9:\"\u0000*\u0000volume\";s:2:\"22\";s:8:\"\u0000*\u0000issue\";s:1:\"9\";s:8:\"\u0000*\u0000spage\";s:4:\"1707\";s:8:\"\u0000*\u0000epage\";s:4:\"1711\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0887-6924\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"FELDMAN\";s:10:\"\u0000*\u0000aufirst\";s:4:\"E. J\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:22:{i:0;s:9:\"CORTES, J\";i:1;s:11:\"MALOISEL, F\";i:2;s:11:\"COLOMBAT, P\";i:3;s:13:\"MARTINELLI, G\";i:4;s:13:\"NIELSEN, J. L\";i:5;s:13:\"PETERSDORF, S\";i:6;s:10:\"GUILHOT, F\";i:7;s:9:\"BARKER, J\";i:8;s:14:\"KIRSCHMEIER, P\";i:9;s:8:\"FRANK, E\";i:10;s:13:\"STATKEVICH, P\";i:11;s:14:\"DEANGELO, D. J\";i:12;s:6:\"ZHU, Y\";i:13;s:11:\"LOECHNER, S\";i:14;s:7:\"LIST, A\";i:15;s:11:\"HOLYOAKE, T\";i:16;s:12:\"SIMONSSON, B\";i:17;s:13:\"O'BRIEN, S. G\";i:18;s:11:\"REIFFERS, J\";i:19;s:12:\"TURNER, A. R\";i:20;s:11:\"ROBOZ, G. J\";i:21;s:12:\"LIPTON, J. H\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"LEUKED\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:88:\"On the use of lonafarnib in myelodysplastic syndrome and chronic myelomonocytic leukemia\";s:8:\"\u0000*\u0000place\";s:6:\"London\";s:6:\"\u0000*\u0000pub\";s:17:\"Nature Publishing\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"5\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:20:\"10.1038\/leu.2008.156\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:88:\"On the use of lonafarnib in myelodysplastic syndrome and chronic myelomonocytic leukemia\";s:9:\"\u0000*\u0000jtitle\";s:8:\"Leukemia\";s:9:\"\u0000*\u0000stitle\";s:8:\"Leukemia\";s:7:\"\u0000*\u0000date\";s:4:\"2008\";s:9:\"\u0000*\u0000volume\";s:2:\"22\";s:8:\"\u0000*\u0000issue\";s:1:\"9\";s:8:\"\u0000*\u0000spage\";s:4:\"1707\";s:8:\"\u0000*\u0000epage\";s:4:\"1711\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0887-6924\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"FELDMAN\";s:10:\"\u0000*\u0000aufirst\";s:4:\"E. J\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:22:{i:0;s:9:\"CORTES, J\";i:1;s:11:\"MALOISEL, F\";i:2;s:11:\"COLOMBAT, P\";i:3;s:13:\"MARTINELLI, G\";i:4;s:13:\"NIELSEN, J. L\";i:5;s:13:\"PETERSDORF, S\";i:6;s:10:\"GUILHOT, F\";i:7;s:9:\"BARKER, J\";i:8;s:14:\"KIRSCHMEIER, P\";i:9;s:8:\"FRANK, E\";i:10;s:13:\"STATKEVICH, P\";i:11;s:14:\"DEANGELO, D. J\";i:12;s:6:\"ZHU, Y\";i:13;s:11:\"LOECHNER, S\";i:14;s:7:\"LIST, A\";i:15;s:11:\"HOLYOAKE, T\";i:16;s:12:\"SIMONSSON, B\";i:17;s:13:\"O'BRIEN, S. G\";i:18;s:11:\"REIFFERS, J\";i:19;s:12:\"TURNER, A. R\";i:20;s:11:\"ROBOZ, G. J\";i:21;s:12:\"LIPTON, J. H\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"LEUKED\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:88:\"On the use of lonafarnib in myelodysplastic syndrome and chronic myelomonocytic leukemia\";s:8:\"\u0000*\u0000place\";s:6:\"London\";s:6:\"\u0000*\u0000pub\";s:17:\"Nature Publishing\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"5\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:20:\"10.1038\/leu.2008.156\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:88:\"On the use of lonafarnib in myelodysplastic syndrome and chronic myelomonocytic leukemia\";s:9:\"\u0000*\u0000jtitle\";s:8:\"Leukemia\";s:9:\"\u0000*\u0000stitle\";s:8:\"Leukemia\";s:7:\"\u0000*\u0000date\";s:4:\"2008\";s:9:\"\u0000*\u0000volume\";s:2:\"22\";s:8:\"\u0000*\u0000issue\";s:1:\"9\";s:8:\"\u0000*\u0000spage\";s:4:\"1707\";s:8:\"\u0000*\u0000epage\";s:4:\"1711\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0887-6924\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"FELDMAN\";s:10:\"\u0000*\u0000aufirst\";s:4:\"E. J\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:22:{i:0;s:9:\"CORTES, J\";i:1;s:11:\"MALOISEL, F\";i:2;s:11:\"COLOMBAT, P\";i:3;s:13:\"MARTINELLI, G\";i:4;s:13:\"NIELSEN, J. L\";i:5;s:13:\"PETERSDORF, S\";i:6;s:10:\"GUILHOT, F\";i:7;s:9:\"BARKER, J\";i:8;s:14:\"KIRSCHMEIER, P\";i:9;s:8:\"FRANK, E\";i:10;s:13:\"STATKEVICH, P\";i:11;s:14:\"DEANGELO, D. J\";i:12;s:6:\"ZHU, Y\";i:13;s:11:\"LOECHNER, S\";i:14;s:7:\"LIST, A\";i:15;s:11:\"HOLYOAKE, T\";i:16;s:12:\"SIMONSSON, B\";i:17;s:13:\"O'BRIEN, S. G\";i:18;s:11:\"REIFFERS, J\";i:19;s:12:\"TURNER, A. R\";i:20;s:11:\"ROBOZ, G. J\";i:21;s:12:\"LIPTON, J. H\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"LEUKED\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:88:\"On the use of lonafarnib in myelodysplastic syndrome and chronic myelomonocytic leukemia\";s:8:\"\u0000*\u0000place\";s:6:\"London\";s:6:\"\u0000*\u0000pub\";s:17:\"Nature Publishing\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"5\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
